TGF-β signaling: critical nexus of fibrogenesis and cancer

AO Giarratana, CM Prendergast, MM Salvatore… - Journal of Translational …, 2024 - Springer
The transforming growth factor-beta (TGF-β) signaling pathway is a vital regulator of cell
proliferation, differentiation, apoptosis, and extracellular matrix production. It functions …

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non–small cell lung cancer: a review

S Singhal, A Vachani, D Antin-Ozerkis, LR Kaiser… - Clinical Cancer …, 2005 - AACR
Lung cancer is the leading cause of cancer death in the US with survival restricted to a
subset of those patients able to undergo surgical resection. However, even with surgery …

Transforming growth factor‐β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

Y Hasegawa, S Takanashi, Y Kanehira, T Tsushima… - Cancer, 2001 - Wiley Online Library
BACKGROUND Transforming growth factor‐β1 (TGF‐β1) is a multifunctional factor and is
known to affect tumor growth in malignant tumors. The effects of TGF‐β1 on angiogenesis …

Exploring anti-TGF-β therapies in cancer and fibrosis

LJAC Hawinkels, P Ten Dijke - Growth factors, 2011 - Taylor & Francis
Transforming growth factor-β (TGF-β) is a multifunctional cytokine, with important roles in
maintaining tissue homeostasis. TGF-β signals via transmembrane serine/threonine kinase …

[HTML][HTML] Molecular pathogenesis of lung cancer

KM Fong, Y Sekido, JD Minna - The Journal of thoracic and cardiovascular …, 1999 - Elsevier
Lung cancer is the largest cancer killer of men and women in the united states. In addition to
the progress made from antismoking primary prevention measures, new tools to help treat …

Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

CQ Zhu, W Shih, CH Ling, MS Tsao - Journal of clinical pathology, 2006 - jcp.bmj.com
Characteristics of the tumour that affect and predict the survival outcome of patients with
cancer are prognostic markers for cancer. In non-small cell lung carcinoma (NSCLC), stage …

CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling

Z Ying, H Tian, Y Li, R Lian, W Li, S Wu… - The Journal of …, 2017 - Am Soc Clin Investig
Paradoxically, during early tumor development in many cancer types, TGF-β acts as a tumor
suppressor, whereas in the advanced stages of these cancers, increased TGF-β expression …

[HTML][HTML] Mechanisms of immune response regulation in lung cancer

J Domagala-Kulawik, I Osinska… - Translational lung cancer …, 2014 - ncbi.nlm.nih.gov
Lung cancer is a leading cause of cancer deaths. As a solid tumor with low antigenicity and
heterogenic phenotype lung cancer evades host immune defense. The cytotoxic anticancer …

α2HS-glycoprotein, an Antagonist of Transforming Growth Factor β In vivo, Inhibits Intestinal Tumor Progression

CJ Swallow, EA Partridge, JC Macmillan, T Tajirian… - Cancer research, 2004 - AACR
Transforming growth factor (TGF)-β1 is associated with tumor progression and resistance to
chemotherapy in established cancers, as well as host immune suppression. Here, we show …

Repression of Tif1γ by SOX2 promotes TGF-β-induced epithelial–mesenchymal transition in non-small-cell lung cancer

L Wang, H Yang, Z Lei, J Zhao, Y Chen, P Chen, C Li… - Oncogene, 2016 - nature.com
TIF1γ is a novel regulator of transforming growth factor (TGF)-β/Smad signaling. Our
previous studies show that dysregulated expression of transcriptional intermediary factor 1 γ …